The company has launched Tacrolimus capsules USP in the strengths of 0.5 mg, 1 mg, and 5 mg, after Concord Biotech Ltd received an approval for its abbreviated new drug application (ANDA) from the United States Food and Drug Administration (USFDA), Lupin said in a regulatory filing.from Moneycontrol Business News https://ift.tt/39fzDkL
No comments:
Post a Comment